Vicarious Surgical Inc. (RBOT), a next-generation robotics technology company, Thursday announced the appointment of Sarah Romano as Chief Financial Officer, with effect from April 1.
Romano will lead Vicarious Surgical's financial strategy, bringing extensive experience in capital markets. Most recently, Romano was with Entero Therapeutics as CFO.
In the pre-market trading, Vicarious is 3.38% higher at $9.49 on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.